ZNF510 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.64672999999338E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.27849999999696E-05 |
Normal-vs-Stage2 |
2.794400E-02 |
Normal-vs-Stage3 |
7.430500E-04 |
Normal-vs-Stage4 |
3.042000E-02 |
Stage1-vs-Stage2 |
7.768600E-01 |
Stage1-vs-Stage3 |
6.066600E-01 |
Stage1-vs-Stage4 |
5.717000E-01 |
Stage2-vs-Stage3 |
5.241600E-01 |
Stage2-vs-Stage4 |
5.063000E-01 |
Stage3-vs-Stage4 |
8.223800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.18479999999355E-05 |
Normal-vs-AfricanAmerican |
3.597900E-04 |
Normal-vs-Asian |
1.206210E-04 |
Caucasian-vs-AfricanAmerican |
9.821600E-01 |
Caucasian-vs-Asian |
2.059800E-01 |
AfricanAmerican-vs-Asian |
1.612630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.85809999947639E-07 |
Normal-vs-Female |
8.458200E-02 |
Male-vs-Female |
1.523540E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.430000E-04 |
Normal-vs-Extreme_Weight |
2.45190000003337E-06 |
Normal-vs-Obese |
6.135500E-03 |
Normal-vs-Extreme_Obese |
3.566800E-04 |
Normal_Weight-vs-Extreme_Weight |
5.505200E-01 |
Normal_Weight-vs-Obese |
3.443000E-01 |
Normal_Weight-vs-Extreme_Obese |
5.170600E-01 |
Extreme_Weight-vs-Obese |
7.924500E-02 |
Extreme_Weight-vs-Extreme_Obese |
7.616400E-01 |
Obese-vs-Extreme_Obese |
2.155400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.639840E-04 |
Normal-vs-Age(41-60Yrs) |
1.806250E-02 |
Normal-vs-Age(61-80Yrs) |
1.52070000036808E-07 |
Normal-vs-Age(81-100Yrs) |
8.10820000000101E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.958200E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.724200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.779400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.735900E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.929800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.636800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.58059999999716E-05 |
Normal-VS-Type2 PRCC |
1.44509999999709E-06 |
Normal-VS-KIRP CIMP |
1.035850E-03 |
Normal-VS-Unclassified PRCC |
2.725200E-01 |
Type1 PRCC-VS-Type2 PRCC |
5.532200E-02 |
Type1 PRCC-VS-KIRP CIMP |
2.788600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.572780E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.020400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.087600E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.431820E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.4602999071941E-10 |
Normal-vs-N1 |
1.849890E-02 |
Normal-vs-N2 |
3.097200E-03 |
N0-vs-N1 |
1.378610E-01 |
N0-vs-N2 |
6.640400E-01 |
N1-vs-N2 |
3.845400E-01 |
|
|